19 February 2022 - These standardised factories could be quickly scaled up to expand capacity worldwide.

At the heart of its site in Marburg, Germany, BioNTech is putting the finishing touches on a new kind of factory. The drug company has spent eight months reworking its manufacturing processes to produce its mRNA COVID-19 vaccine inside a set of standard shipping containers. 

By creating a modular approach to drug manufacturing, Ugur Sahin, BioNTech’s boss, says he aims to transform medicine production around the world.

Read The Economist article